Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Optimal microneedling routine is 1.25mm once a week with Dr Pen 36 needles. Applying Minoxidil right after microneedling may increase systemic absorption risk.

GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.

Mesotherapy with dutasteride is suggested as an effective alternative for those experiencing side effects from oral treatments, as it targets hair follicles directly. While oral treatments are more proven, mesotherapy may offer better localized results without systemic exposure.

A male is considering using a topical formula for women containing Dutasteride, Spironolactone, Ketoconazole, and Minoxidil to stabilize hair loss, questioning if Dutasteride will have systemic effects. The user has been using RU58841 without noticeable results and is frustrated by the lack of feedback.

Fluridil (Eucapil) is discussed as a topical anti-androgen treatment for hair loss, with users considering it alongside minoxidil and comparing it to finasteride. Some users express interest in its potential due to minimal systemic side effects, while others mention using alternatives like RU58841 and dutasteride.

Mesotherapy Dutasteride is considered highly effective for reducing scalp DHT and potentially reversing hair loss. However, one user reported systemic side effects and no improvement in hair loss.

Topical dutasteride with microneedling and mesotherapy dutasteride injections are effective treatments for androgenetic alopecia in both men and women. These methods offer promising alternatives to oral therapies with potentially fewer systemic side effects.

A user is using a custom hair loss lotion containing 0.1% topical finasteride and 5% minoxidil, expressing concerns about potential systemic absorption and dosage. They are considering adjusting their regimen and seeking advice on whether to reduce finasteride concentration or change application frequency.

Future hair loss treatments may focus on topicals like Pyrilutamide and GT20029 to target DHT sensitivity in the scalp, rather than systemic DHT reduction like finasteride. Oral DHT blockers are still considered necessary for effective treatment in the near future.

The user is experiencing low libido and erectile dysfunction from oral dutasteride and is considering switching to topical treatments, including RU58841. They are also concerned about applying hair products after using RU58841 to avoid systemic absorption.

The user is using 0.1% dutasteride, 1% minoxidil with 2% procapil and 0.005% caffeine in the morning, and 1% minoxidil with 2% procapil and 0.01% tretinoin at night. They are concerned about the solution vehicle's effectiveness in preventing systemic absorption and ensuring the products stay around the hair follicles.

Dutasteride mesotherapy is being considered as a treatment for hair loss, with users seeking insights on its effectiveness and potential side effects. Concerns are raised about systemic effects due to previous negative experiences with finasteride.

The conversation discusses using RU58841 and finasteride for hair loss, with questions about RU58841's storage, systemic effects, and application concerns. Users suggest using a PG-free carrier to minimize systemic absorption and caution against buying RU58841 from unreliable sources.

RU58841 should be applied directly to the scalp, ideally once a day, a few hours before bed. Some users experienced side effects like shedding and systemic issues when using RU58841 and Minoxidil together, while others reported no side effects when using RU58841 alone.

GT20029 may not permanently destroy androgen receptors, requiring ongoing application for hair maintenance. Concerns exist about potential systemic effects if androgen receptors are permanently degraded.

The conversation discusses the appropriate concentration of topical finasteride for hair loss treatment, with users debating between 0.1%, 0.15%, and lower percentages to minimize systemic effects. The discussion also mentions using Minoxidil and questions the accuracy of a calculator for determining the correct dosage.

Pyrilutamide is believed to be more effective than RU58841 and 1 mg finasteride in treating hair loss, with no systemic hormonal effects and the potential to block more than 31% of scalp DHT. It may also antagonize scalp testosterone due to its action as an androgen receptor antagonist.

Dutasteride mesotherapy may not affect serum DHT levels significantly and its impact on scalp DHT is uncertain. Its systemic accumulation depends on dose and frequency.

The user is exploring topical Saw Palmetto as a milder alternative to microdosing topical Finasteride for hair loss, aiming to minimize systemic DHT impact. They plan to experiment with this herbal remedy for a year to assess its effectiveness on their mild androgenetic alopecia without significant side effects.

User started using topical spironolactone on scalp and face, experienced fever feeling and sluggishness. Asks if side effects are normal or systemic.

Topical retinol does not affect hair loss and may help hair regrowth. It is different from isotretinoin, which can cause hair loss due to its systemic effects.

The conversation discusses hair loss treatments, focusing on the anti-androgen component CB 03 01 and its systemic absorption and safety compared to finasteride. It highlights concerns about inhibiting DHT conversion and the safety of using clascoterone for hair loss.

A user found that antihistamines stop their hair loss and related symptoms, but they experience side effects like sedation and chest pain. They are seeking alternative solutions or topical antihistamines to avoid systemic side effects.

Kintor's Pyrilutamide results for hair loss treatment will be released soon. The treatment may replace current treatments like finasteride and minoxidil without systemic side effects.

Ell-Cranell and Eucapil are discussed as hair loss treatments, with Ell-Cranell being a weak estrogen and DHT inhibitor that may reduce hair loss without systemic side effects. Alfatradiol is the active ingredient in these products.

The user experienced side effects like fatigue and aches after using Eucapil 2% for hair loss, suspecting it went systemic. Other users debated whether Eucapil can cause such effects, with some suggesting it might affect testosterone levels.

The conversation discusses using topical dutasteride from minoxidilmax for hair loss and the possibility of crowdfunding for DHT blood tests to check if the treatment goes systemic. The user plans to post before and after pictures.

The conversation discusses finding a finasteride dosage that reduces DHT by about 25% to minimize side effects, with considerations for topical versus oral formulations. Alternatives like dutasteride mesotherapy and topical treatments are explored, with concerns about systemic absorption and potential impacts on athletic performance and hormone levels.

A user shared their experience with microneedling and minoxidil for hair loss, avoiding finasteride due to concerns about systemic hormone effects. They reported slight hair regrowth after one month and plan to continue the regimen, noting improvements in skin sensitivity and managing dandruff with anti-dandruff shampoo.

Hair loss treatments discussed include Minoxidil, Finasteride, RU58841, Alfatradiol, and Eucapil. Topical treatments must penetrate skin and may go systemic, with effectiveness varying.